OakChart

Cibus Inc

CBUSHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 3:37 PM ET

1.17+0.02 (2.18%)
2026-11-11 21:37 CET
Market cap
87.51 USD m
Revenue, TTM
4.35 USD m
Net income, TTM
-98.19 USD m
Free cash flow, TTM
-46.32 USD m
EPS diluted, TTM
-1.65
P/E
-
Compare

Price

CBUS against its 20, 50 and 200-day averages
2050200earnings
1.001.502.002.501.0M2.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CBUSclose 1.1720-day 1.2950-day 1.45200-day 1.821.1752w low

72.1% under the 52-week high of 4.19 on 11 Mar 2026. 52-week low 1.07 on 10 Nov 2026. Last 15 sessions, 37.4% high to low

Volume 0.60× normal · the line is the 50-bar volume average

Profile

CBUS
52-week range, 3% of the way up
1.074.19

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as canola, rice, soybean, corn and wheat. The company was founded by Rory Balfour Riggs, Peter Beetham and Greg Gocal in 2001 and is headquartered in San Diego, CA.

Employees118
IPOJul 20, 2017
Beta1.65
ATR, 14d0.13
Rel volume0.60
Short float6.57%
Insider own38.65%
Inst own25.19%

Snapshot

6 groups

Valuation

Index-
Market Cap89.42M
Enterprise Value355.25M
Income-98.19M
Sales4.35M
Book/sh0.19
Cash/sh0.27
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees118
IPOJul 20, 2017

Ratios

P/E-
Forward P/E-
PEG-
P/S20.56
P/B6.04
P/C4.38
P/FCF-
EV/EBITDA-
EV/Sales81.67
Quick Ratio1.62
Current Ratio1.62
Debt/Eq19.34
LT Debt/Eq19.09
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.65
EPS next Y-0.64
EPS next Q-0.20
EPS this Y69.54%
EPS next Y24.80%
EPS next 5Y51.36%
EPS past 3/5Y46.72% 46.96%
Sales past 3/5Y185.12% -31.34%
EPS Y/Y TTM84.17%
Sales Y/Y TTM-10.30%
EPS Q/Q52.67%
Sales Q/Q6.54%
EarningsNov 12 AMC
EPS/Sales Surpr.-52.63% -41.67%

Ownership

Insider Own38.65%
Insider Trans0.00%
Inst Own25.19%
Inst Trans-7.02%
ROA-29.77%
ROE-225.93%
ROIC-33.02%
Gross Margin-17.97%
Oper. Margin-1240.90%
Profit Margin-2258.89%
SMA20-9.16%
SMA50-19.47%
SMA200-35.88%
Trades-

Technical

Shs Outstand76.42M
Shs Float46.89M
Short Float6.57%
Short Ratio27.70
Short Interest3.08M
52W High4.19 -72.08%
52W Low1.07 9.35%
Volatility15.16% 10.59%
ATR (14)0.13
RSI (14)37.09
Beta1.65
Rel Volume0.60
Avg Volume111.27K
Volume63,420

Performance

Perf Week-5.65%
Perf Month-17.02%
Perf Quarter-38.42%
Perf Half Y-19.59%
Perf YTD-32.76%
Perf Year-11.36%
Perf 3Y-92.06%
Perf 5Y-99.34%
Perf 10Y-
Recom1.67
Target Price14.33
Prev Close1.14
Price1.17
Change %2.18%

Analyst ratings

latest 4 of 4
DateActionAnalystRating changeTargetImplied
Jul 29, 2024InitiatedAAlliance Global PartnersBuy$25+2,036.8%
Jul 19, 2024ResumedCCanaccord GenuityBuy$22+1,780.3%
Oct 09, 2023InitiatedHH.C. WainwrightBuy$25+2,036.8%
Jul 19, 2023ResumedCCanaccord GenuityBuy$30+2,464.1%

Peers

Mkt cap
TickerCompanyMkt cap
EVGNEvogene Ltd6.97M
DNAGinkgo Bioworks Holdings Inc708.62M
DTILPrecision Biosciences Inc257.01M
CRBUCaribou Biosciences Inc42.15M
MLECMoolec Science SA0.62M
BIOXBioceres Crop Solutions Corp14.81M
CTVACorteva Inc8.13B
FMCFMC Corp889.02M
AVDAmerican Vanguard Corp26.11M
SMGScotts Miracle-Gro Company3.79B

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
KROPGlobal X AgTech & Food Innovation ETFAUM: 15.34M

News

latest 14 of 198

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.203--1.303
2026Q22026-08-13-0.290-0.190-0.2900.991.702
2026Q12026-05-14-0.330-0.270-0.3261.681.613
2025Q42026-03-17-0.590-0.353-0.5891.061.644
2025Q32025-11-13-0.440-0.438-0.4450.621.394
2025Q22025-08-14-0.610-0.603-0.6100.931.144
2025Q12025-05-08-1.340-0.583-1.3381.031.143
2024Q42025-03-20-0.870-0.677-0.8271.211.153
2024Q32024-11-07-7.630-0.873-7.6301.670.653
2024Q22024-08-08-1.140-0.813-1.1390.840.473
2024Q12024-05-09-1.120-1.010-1.1230.550.401
2023Q42024-03-21-12.590-1.430-12.5901.100.383
2023Q32023-11-09-1.590-1.170-1.5880.480.253
2023Q22023-08-09-3.050-0.300-3.0460.20-1
2023Q12023-05-01-5.450-3.000-10.9180.04-1
2022Q42023-03-02-3.000-5.500-2.9280.041.081

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-60.500-57.833-60.3747.307.38
2020FY-59.500-60.300-66.16423.8520.43
2021FY-39.000-43.375-38.95725.9927.14
2022FY-18.500-21.000-18.3610.160.20
2023FY-25.950-7.550-25.9471.821.13
2024FY-10.830-7.760-10.8254.264.15
2025FY-2.780-2.310-2.7803.644.05
2026FY--0.847--5.20
2027FY--0.637--12.43
2028FY--0.320--47.55
2029FY-0.510--144.84
2030FY-2.065--329.08

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-282001.301.201.40
2026Q3S2026-08-142021.301.201.40
2026Q3S2026-08-132002.021.552.50
2026Q3S2026-07-292002.021.552.50
2026Q3S2026-07-222102.021.552.50
2026Q3S2026-05-153202.031.552.50
2026Q3S2026-03-263011.971.502.50
2026Q3S2026-03-182012.201.902.50
2026Q3S2026-01-282002.502.502.50
2026Q3S2025-11-142102.502.502.50
2026Q3S2025-11-112002.292.082.50
2026Q3S2025-11-102002.292.082.50
2026Q3S2025-11-092002.292.082.50
2026Q3S2025-11-082002.292.082.50

Estimate history

EPS, annual-46.864-45.46-60.374-66.164-38.957-18.361-25.947-10.825-2.777-1.6474
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.139-7.63-0.827-1.338-0.61-0.445-0.589-0.326-0.289
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.5080.2367.29623.85125.9870.1571.8174.2623.6394.35
Period201720182019202020212022202320242025TTM
Sales, quarterly0.8381.6671.2121.0340.9330.6151.0571.6810.994
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.5540.6530.6590.7410.7750.97720.56827.93954.32676.423
Period201720182019202020212022202320242025MRQ
Shares, quarterly23.01526.4327.93932.65852.4852.56754.32676.28376.423
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue4.353.644.261.820.1625.9923.857.300.24
Cost of Goods Sold Incl. D&A5.135.926.864.691.5328.5635.149.201.08
Gross Profit-0.78-2.28-2.60-2.88-1.38-2.57-11.29-1.90-0.84
Selling, General and Administrative Excl. Other53.1665.1874.3766.5920.9926.7631.8737.6927.27
Research and Development37.3944.2050.4342.3711.5511.3411.0812.218.77
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-53.94-67.46-76.96-69.46-22.37-29.33-43.16-39.59-28.11
Interest Expense36.6835.0433.5618.360.151.431.441.491.26
Unusual Expense9.1530.51190.73248.29-5.12-1.530.690.000.00
Net Income Before Taxes-99.61-132.17-282.68-337.64-16.89-29.20-44.84-39.61-27.90
Income Taxes0.010.030.03-0.000.000.000.000.000.00
Consolidated Net Income-99.62-132.20-282.71-337.64-16.89-29.20-44.84-39.61-27.90
Net Income From Continuing Operations-98.19-127.08-251.39-267.63-16.89-29.20-44.84-39.61-27.90
Net Income-98.19-127.08-251.39-267.63-16.89-29.20-44.84-39.61-27.90
EPS (Recurring)-1.20-2.31-5.08-9.10-22.26-40.38-65.46-60.37-45.46
EPS (Basic, Before Extraordinaries)-1.65-2.78-10.83-25.95-18.36-38.96-66.16-60.37-45.46
EPS (Diluted)-1.65-2.78-10.83-25.95-18.36-38.96-66.16-60.37-45.46
EBITDA-48.81-61.54-70.11-64.77-20.84-26.99-41.30-37.98-27.03
Non-Operating Income (Expense)0.170.8518.57-1.520.510.040.451.471.48
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.356.478.4912.714.002.094.979.184.38
Price To Sales Ratio24.1921.8815.15111.4943.213.075.9931.521,346.95
Gross Margin-17.97-62.76-60.93-158.28-877.07-9.89-47.35-26.08-358.05
Operating Margin-1,240.90-1,853.92-1,805.82-3,823.00-14,248.41-112.87-180.97-542.65-11,913.14
Net Margin-2,258.89-3,492.31-5,898.36-14,729.06-10,758.60-112.36-187.98-542.93-11,820.76
Shares Outstanding76.4254.3327.9420.570.980.780.740.660.65
Market Capitalization87.5187.5173.55387.226.9082.59156.41230.99338.24

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.991.681.060.610.931.031.211.67
Cost of Goods Sold Incl. D&A1.161.201.381.391.571.631.651.63
Gross Profit-0.170.48-0.32-0.78-0.64-0.60-0.440.04
Selling, General and Administrative Excl. Other12.7612.6013.1414.6617.3020.0217.5919.04
Research and Development8.518.729.3910.7812.2311.8012.4312.99
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-12.93-12.12-13.46-15.44-17.95-20.62-18.02-19.00
Interest Expense9.369.099.358.878.568.268.138.88
Unusual Expense0.05-0.019.100.01-0.0121.410.39189.15
Net Income Before Taxes-22.14-21.21-31.94-24.31-26.53-49.39-25.80-201.45
Income Taxes0.010.010.01-0.010.030.000.010.01
Consolidated Net Income-22.14-21.22-31.95-24.30-26.56-49.39-25.80-201.46
Net Income From Continuing Operations-22.14-21.22-31.29-23.54-25.37-46.89-23.10-179.97
Net Income-22.14-21.22-31.29-23.54-25.37-46.89-23.10-179.97
EPS (Recurring)-0.29-0.33-0.47-0.44-0.61-0.91-0.82-2.02
EPS (Basic, Before Extraordinaries)-0.29-0.33-0.59-0.44-0.61-1.34-0.83-7.63
EPS (Diluted)-0.29-0.33-0.59-0.44-0.61-1.34-0.83-7.63
EBITDA-11.76-10.92-12.08-14.04-16.37-18.99-16.38-17.38
Non-Operating Income (Expense)0.20-0.01-0.040.01-0.030.900.7515.58
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.171.241.441.491.561.972.152.12
Price To Sales Ratio24.1930.1225.4218.0011.8513.8018.2218.51
Gross Margin-16.9028.79-30.09-126.67-68.81-58.03-35.972.22
Operating Margin-1,300.30-721.00-1,273.32-2,510.24-1,923.47-1,994.29-1,487.13-1,140.07
Net Margin-2,227.87-1,262.46-2,959.89-3,827.80-2,719.40-4,534.43-1,906.11-10,795.92
Shares Outstanding76.4276.2854.3352.5752.4832.6627.9426.43
Market Capitalization87.51137.0191.7167.7866.7761.0373.5585.05

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments9.9214.4332.703.5314.3229.3959.0094.1756.66
Short Term Receivables0.701.040.730.000.004.891.120.350.17
Inventories0.000.000.000.000.001.382.590.000.00
Other Current Assets1.441.471.790.610.863.930.811.000.63
Total Current Assets12.0716.9535.224.1315.1839.5963.5295.5257.46
Net Property, Plant & Equipment27.8644.6937.4618.1321.7322.8623.2121.8514.35
Total Investments and Advances0.000.000.000.000.100.601.041.110.00
Intangible Assets264.19287.04470.31------
Other Assets0.931.391.420.160.180.280.320.310.36
Total Assets305.05350.07544.4122.4237.1963.3388.10118.7972.17
Short Term Debt Incl. Current Port. of LT Debt3.174.846.950.460.370.360.360.260.00
Accounts Payable8.075.966.130.341.260.931.080.821.02
Other Current Liabilities5.629.088.250.863.225.655.765.933.23
Total Current Liabilities16.8619.8821.321.664.856.957.207.004.25
Long Term Debt264.80230.89182.9313.4517.5119.3918.2418.2310.15
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.561.471.870.080.700.110.150.160.29
Total Liabilities283.22252.24206.1215.1923.0626.4525.5925.3914.69
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity21.8392.16293.477.2314.1336.8862.5193.4057.48
Total Shareholders Equity21.8392.16293.477.2314.1336.8862.5193.4057.48
Accumulated Minority Interest0.005.6744.820.000.000.000.000.000.00
Total Equity21.8397.83338.297.2314.1336.8862.5193.4057.48
Total Liabilities & Stockholders Equity305.05350.07544.4122.4237.1963.3388.10118.7972.17
Book Value Per Share0.403.3014.277.4018.2249.7494.85143.03103.68
Tangible Book Value Per Share-4.46-6.98-8.607.4018.2249.7494.85143.03103.68
Full-Time Employees118159183485559755035
Price to Book Ratio5.910.680.710.785.844.243.703.629.82
Return on Assets-38.80-56.21-94.43-56.67-58.10-59.22-38.29-29.22-58.52
Return on Equity-222.98-130.38-178.00-158.12-114.49-90.23-50.82-36.98-73.60
Return on Invested Capital-44.34-77.82-56.18-81.68-92.29-79.68-49.05-24.99-38.42
Quick Ratio0.720.851.652.493.135.508.4713.6413.51
Current Ratio0.720.851.652.493.135.708.8313.6413.51

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-99.62-132.20-282.71-337.64-16.89-29.20-44.84-39.61-27.90
Depreciation5.075.926.864.691.532.341.871.611.08
Other Funds (Non Cash)52.8373.37217.43285.77-1.120.564.979.184.40
Funds from Operations-41.71-52.91-58.43-47.17-16.48-26.30-38.00-28.83-22.42
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-4.342.320.380.96-2.887.49-5.68-3.122.17
Cash from Operating Activities-46.05-50.59-58.04-46.21-19.36-18.81-43.67-31.95-20.25
Capital Expenditures-0.27-0.58-0.81-4.32-1.52-0.50-1.79-2.97-1.85
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.040.000.0059.380.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.0011.70-11.700.000.00
Purchase of Investments0.000.000.000.000.000.00-11.700.000.00
Sale Or Maturity of Investments0.000.000.000.000.0011.700.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.05
Cash from Investing Activities-0.22-0.58-0.8155.06-1.5211.20-13.48-2.97-1.80
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock31.6547.9041.6918.7610.374.1114.250.3459.43
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00-0.23
Sale of Common Pref Stock31.6547.9041.6918.7610.374.1114.250.3459.66
Proceedsfrom Stock Options31.6547.9041.6918.7610.373.8814.040.0057.04
Issuance or Reduction of Debt, Net-1.18-1.11-0.88-0.19-0.38-0.361.160.141.24
Change in Long Term Debt-1.18-1.11-0.88-0.19-0.38-0.361.160.141.24
Issuance of Long Term Debt0.000.000.201.380.000.001.520.411.24
Reduction of Long Term Debt-1.18-1.11-1.08-1.57-0.38-0.36-0.36-0.280.00
Net Financing Active Other Cash Flow-0.22-0.14-0.211.760.000.000.00-0.810.00
Other Financing Activities Uses-0.22-0.14-0.21-0.740.000.000.00-0.810.00
Cash from Financing Activities30.2546.6540.6020.329.993.7415.41-0.3360.67
Exchange Rate Effect-0.010.01-0.010.00-----
Net Change in Cash-16.03-4.51-18.2729.17-10.89-3.87-41.75-35.2538.62
Free Cash Flow-46.32-51.17-58.85-50.53-20.88-19.31-45.46-34.92-22.10
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments20.4330.329.9223.8936.4623.59
Short Term Receivables1.141.800.700.701.050.95
Inventories0.000.000.000.000.000.00
Other Current Assets1.890.941.441.652.321.35
Total Current Assets23.4633.0712.0726.2439.8425.88
Net Property, Plant & Equipment25.9326.5727.8638.3340.1842.47
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets263.29263.74264.19264.65265.11265.56
Other Assets0.770.820.931.011.071.14
Total Assets313.45324.20305.05330.23346.20335.05
Short Term Debt Incl. Current Port. of LT Debt3.672.963.173.374.124.88
Accounts Payable5.615.418.075.985.936.78
Other Current Liabilities5.165.585.6211.2112.379.36
Total Current Liabilities14.4513.9416.8620.5622.4221.01
Long Term Debt282.59273.19264.80256.10247.78238.58
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities1.611.581.561.541.511.49
Total Liabilities298.64288.72283.22278.20271.72261.09
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity14.8035.4821.8350.4072.1270.27
Total Shareholders Equity14.8035.4821.8350.4072.1270.27
Accumulated Minority Interest0.000.000.001.632.353.68
Total Equity14.8035.4821.8352.0374.4873.96
Total Liabilities & Stockholders Equity313.45324.20305.05330.23346.20335.05
Book Value Per Share0.190.470.400.961.372.15
Tangible Book Value Per Share-3.25-2.99-4.46-4.08-3.68-5.98
Full-Time Employees--118---
Price to Book Ratio5.914.931.810.940.640.57
Return on Assets-29.77-30.77-38.80-34.06-61.21-63.32
Return on Equity-225.93-191.81-222.98-149.99-160.72-157.73
Return on Invested Capital-7.45-6.88-10.92-7.68-7.93-15.18
Quick Ratio1.622.370.721.281.781.23
Current Ratio1.622.370.721.281.781.23

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-22.14-21.22-31.95-24.30-26.56-49.39
Depreciation1.161.201.291.421.571.63
Other Funds (Non Cash)10.9110.7020.3210.9010.6831.46
Funds from Operations-10.07-9.32-10.34-11.98-14.30-16.29
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.67-2.16-3.080.240.704.47
Cash from Operating Activities-9.41-11.49-13.42-11.74-13.60-11.83
Capital Expenditures0.04-0.12-0.09-0.11-0.09-0.29
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.040.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.04-0.07-0.09-0.11-0.09-0.29
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.4032.300.00-0.2526.7221.43
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.4032.300.00-0.2526.7221.43
Proceedsfrom Stock Options-0.4032.300.00-0.2526.7221.43
Issuance or Reduction of Debt, Net-0.09-0.26-0.39-0.44-0.13-0.15
Change in Long Term Debt-0.09-0.26-0.39-0.44-0.13-0.15
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.09-0.26-0.39-0.44-0.13-0.15
Net Financing Active Other Cash Flow-0.04-0.08-0.07-0.03-0.03-0.01
Other Financing Activities Uses-0.04-0.08-0.07-0.03-0.03-0.01
Cash from Financing Activities-0.5331.96-0.46-0.7226.5621.27
Exchange Rate Effect-0.00-0.000.00-0.000.010.00
Net Change in Cash-9.9020.40-13.96-12.5812.889.15
Free Cash Flow-9.37-11.60-13.51-11.85-13.70-12.12

Revenue breakdown

Total Agricultural Chemicals revenue2024: 4.26M 2025: 3.64M
United States2024: 4.26M 2025: 3.64M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.57%3.1M46.9M116.08K
2026-10-156.67%3.1M46.9M136.74K
2026-09-307.07%3.3M46.9M236.37K
2026-09-157.36%3.5M46.9M263.48K
2026-08-317.40%3.5M46.9M289.15K
2026-08-147.22%3.4M46.9M322.89K
2026-07-317.73%3.6M46.8M338.63K
2026-07-157.50%3.5M46.8M398.62K
2026-06-309.89%4.6M46.8M405.47K
2026-06-1510.47%4.9M46.8M511.97K
2026-05-2910.24%4.8M46.8M538.15K
2026-05-159.91%4.6M46.8M624.36K
2026-04-309.45%4.4M46.8M637.75K
2026-04-158.70%4.1M47.2M628.80K
2026-03-318.01%3.4M42.8M558.47K
2026-03-134.80%2.1M42.8M416.55K
2026-02-274.97%2.0M40.9M377.80K
2026-02-134.55%1.9M40.9M266.93K
2026-01-305.16%1.7M32.7M240.68K
2026-01-153.42%1.2M33.7M242.83K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.001.300.0913.9321.000.000.772-0.0440.001
call5.000.001.300.0016.2950.000.000.760-0.0530.001
call7.500.001.300.0017.4980.000.000.755-0.0580.001
put2.500.752.250.0018.4260.000.00-0.231-0.0430.001
put5.003.204.800.0021.8210.000.00-0.241-0.0510.001
put7.505.807.300.0022.7080.000.00-0.251-0.0530.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-06-23S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-23S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-098-KCurrent report2026-06-08SEC
2026-06-058-KCurrent report2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-05-22EFFECTEffectiveness filing by commission orderSEC
2026-05-22424B3SEC
2026-05-22424B2SEC
2026-05-20CORRESPSEC
2026-05-19UPLOADUpload SubmissionSEC
2026-05-15S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-148-KCurrent report2026-05-14SEC
2026-05-06SCHEDULE 13G/ASEC
2026-04-284/A2026-04-24SEC
2026-04-284Statement of changes in beneficial ownership of securities2026-04-24SEC
2026-04-284Statement of changes in beneficial ownership of securities2026-04-24SEC
2026-04-284Statement of changes in beneficial ownership of securities2026-04-24SEC
2026-04-284Statement of changes in beneficial ownership of securities2026-04-24SEC
2026-04-284Statement of changes in beneficial ownership of securities2026-04-24SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
FMR LLC15.00%
VANGUARD CAPITAL MANAGEMENT LLC3.01%
Transce3nd, LLC0.95%
GEODE CAPITAL MANAGEMENT, LLC0.78%
UNITED CAPITAL FINANCIAL ADVISORS, LLC0.75%
BlackRock, Inc.0.65%
CERTIOR FINANCIAL GROUP, LLC0.46%
VANGUARD FIDUCIARY TRUST CO0.41%
Squarepoint Ops LLC0.41%
Corient Private Wealth LP0.22%

Funds

Fund% owned
Fidelity Growth Company Fund4.45%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.10%
Fidelity Growth Company K6 Fund1.28%
Fidelity Series Growth Company Fund1.11%
Fidelity Blue Chip Growth Fund0.93%
VANGUARD EXTENDED MARKET INDEX FUND0.83%
Fidelity Extended Market Index Fund0.34%
iShares Micro-Cap ETF0.26%
Fidelity Series Blue Chip Growth Fund0.18%
Fidelity Blue Chip Growth K6 Fund0.16%

OakChart. CBUS. Cached 15 minutes.

Some panels did not load: insider.